Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy.
about
Nutritional status in relation to treatment modalitiesAnalysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer.Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Relationships between patient knowledge and the severity of side effects, daily nutrient intake, psychological status, and performance status in lung cancer patients.Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy.Inflammation and cancer: causes and consequences.Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy.Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients.Prognostic value of PINI index in patients with multiple myeloma.Can complications in febrile neutropenia be predicted? Report from a developing country.The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma.Nutritional screening and early treatment of malnutrition in cancer patients.Nutritional status is superior to the ECOG performance status in predicting the dose-intensity of the GEMOX chemotherapy regimen in patients with advanced cancer.Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma.Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
P2860
Q27027294-FD806C50-1313-4EDD-8727-1DCA4E7E9B6CQ33403054-9A7B23B6-F6A9-41F4-8827-C51B08BE7DC7Q34670717-3C0A88EF-E139-4D7A-8720-5FC901A4DA59Q35934296-7106F915-0646-475D-9862-AE958023DB0AQ36400372-AB77E231-5A2F-471C-927D-231094503E79Q37690562-390105EE-FA5F-4D63-AD68-1F2EAA7E4897Q37902573-ACF59EBF-743F-4958-892C-C7800176C386Q37902946-72973B86-62A0-4B3D-9208-347CE5C3D25BQ39681433-1C8DDEE6-0780-418A-A5B7-13986E580E94Q40177728-59FCC406-15B9-442B-B4AA-F84E2A2E2439Q40387345-62B66F61-6AE2-4AA6-9AF6-944CD85BA227Q42117487-2C844961-4146-44B9-BFCF-9A0139B947D1Q42446024-12345D26-5008-446C-886F-4BF3C1C141F1Q43188323-F3F20755-3176-4C0C-983D-2F7F32E30050Q45902611-F83837CD-7980-412B-838A-72E4251FC7E9
P2860
Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evaluation of the nutritional ...... xicity following chemotherapy.
@ast
Evaluation of the nutritional ...... xicity following chemotherapy.
@en
type
label
Evaluation of the nutritional ...... xicity following chemotherapy.
@ast
Evaluation of the nutritional ...... xicity following chemotherapy.
@en
prefLabel
Evaluation of the nutritional ...... xicity following chemotherapy.
@ast
Evaluation of the nutritional ...... xicity following chemotherapy.
@en
P2093
P356
P1433
P1476
Evaluation of the nutritional ...... xicity following chemotherapy.
@en
P2093
F Goldwasser
J Alexandre
J-L Misset
J-M Gornet
M Gross-Goupil
M-L Nguyen
P356
10.1093/ANNONC/MDG013
P577
2003-01-01T00:00:00Z